NO20001169D0 - 6,9-bro erythromycinderivater - Google Patents

6,9-bro erythromycinderivater

Info

Publication number
NO20001169D0
NO20001169D0 NO20001169A NO20001169A NO20001169D0 NO 20001169 D0 NO20001169 D0 NO 20001169D0 NO 20001169 A NO20001169 A NO 20001169A NO 20001169 A NO20001169 A NO 20001169A NO 20001169 D0 NO20001169 D0 NO 20001169D0
Authority
NO
Norway
Prior art keywords
bridge
erythromycin derivatives
erythromycin
derivatives
bridge erythromycin
Prior art date
Application number
NO20001169A
Other languages
English (en)
Other versions
NO20001169L (no
Inventor
Yat Sun Or
Richard F Clark
Daniel T Chu
Jacob J Plattner
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of NO20001169D0 publication Critical patent/NO20001169D0/no
Publication of NO20001169L publication Critical patent/NO20001169L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO20001169A 1997-09-08 2000-03-07 6,9-bro erythromycinderivater NO20001169L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/925,582 US5780605A (en) 1997-09-08 1997-09-08 6,9-bridged erythromycin derivatives
PCT/US1998/018225 WO1999012947A1 (en) 1997-09-08 1998-09-01 6,9-bridged erythromycin derivatives

Publications (2)

Publication Number Publication Date
NO20001169D0 true NO20001169D0 (no) 2000-03-07
NO20001169L NO20001169L (no) 2000-04-05

Family

ID=25451953

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001169A NO20001169L (no) 1997-09-08 2000-03-07 6,9-bro erythromycinderivater

Country Status (24)

Country Link
US (1) US5780605A (no)
EP (1) EP1015467B1 (no)
JP (1) JP2001515915A (no)
KR (1) KR20010023756A (no)
CN (1) CN1269803A (no)
AR (1) AR015434A1 (no)
AT (1) ATE257484T1 (no)
AU (1) AU9216298A (no)
BG (1) BG104288A (no)
BR (1) BR9812148A (no)
CA (1) CA2301643A1 (no)
CO (1) CO4970722A1 (no)
DE (1) DE69821009T2 (no)
DK (1) DK1015467T3 (no)
ES (1) ES2213915T3 (no)
HU (1) HUP0003571A2 (no)
IL (1) IL134220A0 (no)
NO (1) NO20001169L (no)
PL (1) PL339137A1 (no)
PT (1) PT1015467E (no)
SK (1) SK3032000A3 (no)
TR (1) TR200000620T2 (no)
WO (1) WO1999012947A1 (no)
ZA (1) ZA987688B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7910558B2 (en) * 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US7273853B2 (en) * 2002-05-13 2007-09-25 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives
US6841664B2 (en) * 2002-07-25 2005-01-11 Enanra Pharmaceuticals, Inc. 6,11-4-carbon bridged ketolides
US7464097B2 (en) * 2002-08-16 2008-12-09 Sap Ag Managing data integrity using a filter condition
TW200420573A (en) * 2002-09-26 2004-10-16 Rib X Pharmaceuticals Inc Bifunctional heterocyclic compounds and methods of making and using same
CN1780846A (zh) * 2003-03-05 2006-05-31 Rib-X医药品有限公司 双官能杂环化合物及其制备和使用方法
WO2005042554A1 (en) * 2003-10-30 2005-05-12 Rib-X Pharmaceuticals, Inc. Bifunctional macrolide heterocyclic compounds and methods of making and using the same
JP2007512256A (ja) * 2003-11-18 2007-05-17 リブ−エックス ファーマシューティカルズ,インコーポレイテッド 二官能性マクロライド複素環化合物ならびにこれらを製造する方法およびこれらを使用する方法
US7414030B2 (en) * 2004-01-07 2008-08-19 Enanta Pharmaceuticals, Inc. 6-11 Bicyclic erythromycin derivatives
WO2005070113A2 (en) * 2004-01-09 2005-08-04 Enanta Pharmaceuticals, Inc. 9n-substituted 6-11 bicyclic erythromycin derivatives
WO2005080408A1 (en) * 2004-01-23 2005-09-01 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
US8202843B2 (en) 2004-02-27 2012-06-19 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same
US7384922B2 (en) * 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
US20060252710A1 (en) * 2005-05-04 2006-11-09 Guoqiang Wang 6-11 Bridged oxime erythromycin derivatives
JP2008540432A (ja) * 2005-05-04 2008-11-20 エナンタ ファーマシューティカルズ インコーポレイテッド 6−11橋かけオキシムエリスロマイシン誘導体
CA2699733C (en) * 2007-09-17 2013-01-22 Enanta Pharmaceuticals, Inc. 6,11-bridged biaryl macrolides
US8354383B2 (en) * 2007-09-17 2013-01-15 Enanta Pharmaceuticals, Inc. 6,11-bridged biaryl macrolides
US8273720B2 (en) * 2007-09-17 2012-09-25 Enanta Pharmaceuticals, Inc. 6,11-bicyclolides: bridged biaryl macrolide derivatives
TW200946109A (en) * 2008-05-09 2009-11-16 Enanta Pharm Inc Anti-bacterial activity of 9-hydroxy derivatives 6, 11-bicyclolides

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6248696A (ja) * 1985-08-27 1987-03-03 Kanegafuchi Chem Ind Co Ltd N−〔1(s)−エトキシカルボニル−3−フエニルプロピル〕−l−アラニル−l−プロリンの製造法
KR960000434B1 (ko) * 1986-12-17 1996-01-06 다이쇼 세이야꾸 가부시끼가이샤 에리스로마이신 a유도체 및 그의 제조 방법
DE69317877T2 (de) * 1992-01-21 1998-10-29 Abbott Lab 4''-deoxyerythromycinderivate
US5591837A (en) * 1992-04-22 1997-01-07 Taisho Pharmaceutical Co., Ltd. 5-O-desosaminylerythronolide a derivative
MY113693A (en) * 1992-05-26 2002-05-31 Chugai Pharmaceutical Co Ltd Erythromycin derivatives having an enterokinesis stimulating action
HRP930014A2 (en) * 1993-01-08 1994-08-31 Pliva Pharm & Chem Works 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
US5712253A (en) * 1996-06-18 1998-01-27 Abbott Laboratories Macrocyclic 13-membered ring derivatives of erythromycins A and B

Also Published As

Publication number Publication date
DE69821009D1 (de) 2004-02-12
CN1269803A (zh) 2000-10-11
CO4970722A1 (es) 2000-11-07
ATE257484T1 (de) 2004-01-15
PT1015467E (pt) 2004-05-31
EP1015467A1 (en) 2000-07-05
HUP0003571A2 (hu) 2001-02-28
ZA987688B (en) 1999-02-24
DK1015467T3 (da) 2004-05-03
EP1015467B1 (en) 2004-01-07
DE69821009T2 (de) 2004-11-18
KR20010023756A (ko) 2001-03-26
NO20001169L (no) 2000-04-05
ES2213915T3 (es) 2004-09-01
BG104288A (bg) 2001-01-31
CA2301643A1 (en) 1999-03-18
JP2001515915A (ja) 2001-09-25
US5780605A (en) 1998-07-14
WO1999012947A1 (en) 1999-03-18
PL339137A1 (en) 2000-12-04
TR200000620T2 (tr) 2000-09-21
SK3032000A3 (en) 2000-07-11
IL134220A0 (en) 2001-04-30
BR9812148A (pt) 2000-07-18
AR015434A1 (es) 2001-05-02
AU9216298A (en) 1999-03-29

Similar Documents

Publication Publication Date Title
IS4963A (is) Setnar 6,5-heteró-bísýklískar afleiður
DE69933287D1 (de) 12,13-modifizierte epothilon-derivate
ID29241A (id) Turunan-turunan kinolin teranelasi-1,2
NO2006016I1 (no) 7,8,9,10-tetrahydro-6H-6,10-metanoazepinoÄ4,5-gÜkinoksalintartrat
PT993456E (pt) 4,5-diaril-imidazoles 2-substituidos
IS4970A (is) Setnar 6,6-heteró-bísýklískar afleiður
DK1000048T3 (da) Substituerede 1,2,3,4-tetrahydronapthalenderivater
ATE275151T1 (de) 3,6-ketal-makrolidantibiotika
DK1015467T3 (da) 6,9-brobundne erythromycinderivater
TR28098A (tr) 1,2,4-okzadiazol türevleri.
ATE231847T1 (de) Substituierte 1,2,3,4- tetrahydronaphthalinderivate
ATE239750T1 (de) 6,11-verbrückte erythromycinderivate
TR27961A (tr) Sübstitüe edilmis 1,2,3,4 -tetrahidro-5-nitro-pirimidinler.
TR199802520A3 (tr) 1,3,8-Triaza-spiro(4,5) dekan -4-on türevleri.
ATE246199T1 (de) 3-descladinose-2,3-anhydroerythromycin-derivate
TR199800988A3 (tr) 5' Deoksi-Sitidin türevleri.
EE04089B1 (et) 1,3,4-oksadiasolooni derivaadid
DE69906149T2 (de) 4,5-azolo-oxindole
ZA983902B (en) Erythromycin derivatives.
DK1068200T3 (da) 2,4,4-trisubstituerede-1,3-dioxolanfungicider
ID24047A (id) Turunan 5-tersubstitusi-3-oksaziazolil 1,6-naftiridin-2 1h-on
ID26368A (id) Turunan-turunan 2 deoksi higromisin
TR199700219A3 (tr) 1,25-Dihidroksi-16, 22, 23-Trisdihidro-kolkalsiferol türevleri.
DZ2644A1 (fr) Triazolo-Ä3,4-aÜ-pyridazine substituées en 1,2,4.
TR199700927A3 (tr) N-Benzilazolyum türevleri.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application